Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.

Pelton GH, Soleimani L, Roose SP, Tabert MH, Devanand DP.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):67-9. doi: 10.1097/WAD.0000000000000107. No abstract available.

2.

The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease.

Devier DJ, Pelton GH, Tabert MH, Liu X, Cuasay K, Eisenstadt R, Marder K, Stern Y, Devanand DP.

Int J Geriatr Psychiatry. 2009 Dec;24(12):1335-42. doi: 10.1002/gps.2263.

3.

Olfactory identification deficits and MCI in a multi-ethnic elderly community sample.

Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, Andrews H, Brown TR, DeCarli C, Mayeux R.

Neurobiol Aging. 2010 Sep;31(9):1593-600. doi: 10.1016/j.neurobiolaging.2008.09.008. Epub 2008 Oct 28.

4.

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.

Biol Psychiatry. 2008 Nov 15;64(10):871-9. doi: 10.1016/j.biopsych.2008.06.020. Epub 2008 Aug 23.

5.

Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly.

Louis ED, Marder K, Tabert MH, Devanand DP.

Mov Disord. 2008 Mar 15;23(4):524-30.

6.

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N, Roose SP, Devanand DP.

Int J Geriatr Psychiatry. 2008 Jul;23(7):670-6.

7.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
8.

Validation and optimization of statistical approaches for modeling odorant-induced fMRI signal changes in olfactory-related brain areas.

Tabert MH, Steffener J, Albers MW, Kern DW, Michael M, Tang H, Brown TR, Devanand DP.

Neuroimage. 2007 Feb 15;34(4):1375-90. Epub 2006 Dec 28.

PMID:
17196831
9.

Olfactory dysfunction as a predictor of neurodegenerative disease.

Albers MW, Tabert MH, Devanand DP.

Curr Neurol Neurosci Rep. 2006 Sep;6(5):379-86. Review.

PMID:
16928347
10.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
11.

PET network abnormalities and cognitive decline in patients with mild cognitive impairment.

Devanand DP, Habeck CG, Tabert MH, Scarmeas N, Pelton GH, Moeller JR, Mensh BD, Tarabula T, Van Heertum RL, Stern Y.

Neuropsychopharmacology. 2006 Jun;31(6):1327-34.

12.

A 10-item smell identification scale related to risk for Alzheimer's disease.

Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP.

Ann Neurol. 2005 Jul;58(1):155-60.

PMID:
15984022
13.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
14.

Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).

Scarmeas N, Habeck C, Anderson KE, Hilton J, Devanand DP, Pelton GH, Tabert MH, Flynn J, Park A, Ciappa A, Tycko B, Stern Y.

Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):596-605.

15.

Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Scarmeas N, Habeck CG, Zarahn E, Anderson KE, Park A, Hilton J, Pelton GH, Tabert MH, Honig LS, Moeller JR, Devanand DP, Stern Y.

Neuroimage. 2004 Sep;23(1):35-45.

16.

Lexical emotional expression across the life span: quantitative and qualitative analyses of word list generation tasks.

Tabert MH, Peery S, Borod JC, Schmidt JM, Grunwald I, Sliwinski M.

Clin Neuropsychol. 2001 Dec;15(4):531-50.

PMID:
11935455
17.

Functional deficits in patients with mild cognitive impairment: prediction of AD.

Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP.

Neurology. 2002 Mar 12;58(5):758-64.

PMID:
11889240
18.

The impact of mild cognitive impairment on functional abilities in the elderly.

Albert SM, Tabert MH, Dienstag A, Pelton G, Devanand D.

Curr Psychiatry Rep. 2002 Feb;4(1):64-8. Review.

PMID:
11814398
19.

Differential amygdala activation during emotional decision and recognition memory tasks using unpleasant words: an fMRI study.

Tabert MH, Borod JC, Tang CY, Lange G, Wei TC, Johnson R, Nusbaum AO, Buchsbaum MS.

Neuropsychologia. 2001;39(6):556-73.

PMID:
11257281
20.

Visual target detection paradigm for the study of selective attention.

Tabert MH, Chokron S, Tang CY, Wei T, Brickman AM, Buchsbaum MS.

Brain Res Brain Res Protoc. 2000 Nov;6(1-2):80-5.

PMID:
11086266
21.

Development of procedures for rating posed emotional expressions across facial, prosodic, and lexical channels.

Canino E, Borod JC, Madigan N, Tabert MH, Schmidt JM.

Percept Mot Skills. 1999 Aug;89(1):57-71.

PMID:
10544401

Supplemental Content

Loading ...
Support Center